Consumer Product Service Area Newsletter: February
Cardno ChemRisk offers a variety of expertise relevant for the consumer product industry. Our scientists, led by service area expert Dr. Ernest Fung, provide customized and novel approaches for evaluating consumer product safety.
Come see us at the annual SOT meeting in San Diego, CA
We are presenting several posters related to Consumer Products:
Monday March 28, 2022:
- Assessment of Ethanol Exposure in Nursing Infants from Maternal Hand Sanitizer Use and Potential for Developmental Toxicity (P514; 10:45am to 12:30pm)
- Quantitative Risk Assessment of Skin Sensitization Elicitation following Use of Shampoo Products Containing Formaldehyde-Releasing Preservative DMDM Hydantoin (P519; 10:45am to 12:30pm)
- Assessing Potential Human Exposure to PFAS from Leave-In Dental Products (P216; 10:45am to 12:30pm)
Tuesday March 29, 2022:
- Evaluation of the Safety and Efficacy of Children’s Hand Sanitizers Available during the COVID-19 Pandemic (P664; 9:00am to 10:45am)
- Evaluating Potential Human Exposure to Bisphenol A in Eyeglasses via Hand-to-Mouth Contact (P666; 9:00am to 10:45am)
- Assessing Potential Bladder Cancer Risk Associated with Dermal Exposure to 4-Aminobiphenyl in Consumer Hair Dyes (P560; 10:45am to 12:30pm)
Wednesday March 30, 2022:
- A Review of Chemicals Leached from Virgin PET and Recycled PET Beverage Containers Into Beverages (P659; 2:30pm to 4:15pm)
Join us for our monthly consumer products webinar
Our next webinar entitled “Screening-level risk assessment of PFAS in leave-in dental products” will be given on April 19, 2022.
For more information about upcoming webinars, follow us on LinkedIn. Webinar topics of discussion include:
- Antimicrobials in consumer products
- Contamination in dietary supplements
- Medical device risk assessment
- and many more!
Cardno ChemRisk publications
In a recent publication, Cardno ChemRisk scientists presented a comprehensive assessment of the available data on the carcinogenic hazards associated with cobalt-containing alloys used in implanted medical devices. Based on their research, the authors concluded that the available in vivo models suggest that cobalt-containing alloys do not present a significant carcinogenic risk to human patients.
Please check out our blog for timely discussions on other consumer product related topics.
Meet the authors: